Anti-Microbial Resistance is a significant medical challenge

Problems emerged as microbials no longer respond to medicine

Dr. Bipin Nair, Dean of Life Sciences,Amrita School of Biotechnology, Amrita Vishwa Vidyapeetham speaking at ALARM 2022

Anti-Microbial Resistance (AMR) has emerged as a significant public challenge in recent years where bacteria, viruses, fungi, and parasites no longer respond to medicines, making infections harder to treat and increasing the risk of disease spread, severe illness, and death. 

As a result of drug resistance, antibiotics and other antimicrobial medicines become ineffective, and infections become increasingly difficult or impossible to treat. To combat this menace, a better understanding of resistance mechanisms is needed to facilitate novel approaches to diagnostics and therapeutics. 

“It is evident that several complementary, overlapping, collaborative, and synergistic approaches with unified goals will be essential to ensure, support, and sustain access to effective antimicrobial therapies,” said Dr. Bipin Nair, Dean of Life Sciences at Amrita School of Biotechnology, who has recently been appointed by the Govt. of India as the Vice Chair of the India AMR Innovation Hub (IAIH), a national-level body handling research related to antimicrobial resistance. 

He speaking at Amrita Legion of Antimicrobial Resistance Management (ALARM) 2022, a two-day hybrid Symposium titled “Preventing Antimicrobial Resistance – Together We Can” organized by Amrita Vishwa Vidyapeetham, ranked the 5th Best Overall University in India. The event was held in connection with World Antimicrobial Awareness Week, an initiative launched by the World Health Organization (WHO). The symposium aimed to spread awareness of the burgeoning antibiotic resistance crisis that threatens humanity worldwide.

“Developing appropriate strategies and interventions in the Indian context, planning effective antibiotic stewardship in India, setting pragmatic goals, promoting investments for AMR activities to spread awareness across all segments, research and innovation, and strengthening India’s sustained commitment on AMR are of paramount importance,” Dr. Bipin Nair said. 

Dr. Geetha Kumar, Professor, School of Biotechnology, Amrita Vishwa Vidyapeetham speaking at ALARM 2022

On the occasion, Ph.D. scholars visited 15 schools in Kerala’s Kollam district to educate students about the antimicrobial resistance global crisis. The awareness campaign focused on emergence, transmission, and prevention of antibiotic resistance. The campaign aimed at utilising a wider audience of school students who could, in turn, educate their parents and ultimately create awareness in the community. Various schools in the Kollam district were invited to attend the ALARM 2022 exhibition.

Dr. Taslimarif Saiyed, CEO, Center for Cellular and Molecular Platforms (C-CAMP), in his capacity as coordinator of the India Antimicrobial Resistance Innovation Hub (IAIH), provided insights into the proposed activities of IAIH under the chairmanship of Dr. Ajay Sood, principle scientific advisor to the Prime Minister’s Office and highlighted that India would benefit greatly from the National Action Plan that is being implemented to combat AMR. 

Dr. Victor Nizet, Professor and Vice Chair for Basic Research and Chief, Division of Host-Microbe Systems and Therapeutics, UCSD, California, talked about the exciting use of vaccines in combating prominent microbial multi drug resistant pathogens.

Ph.D. scholars from the Amrita School of Biotechnology, Ms. Amrita Salim and Ms. Nitasha Menon gave research presentations. Students also played a role in the awareness program, staging mimes on antimicrobial resistance and designing awareness posters. A poster-making competition was also organized for the school students.


Please enter your comment!
Please enter your name here